iPark Institute Co., Ltd.
- Other R&D services
Shonan Health Innovation Park (Shonan iPark) is Japan's first pharmaceutical-initiated science park, established in April 2018 when Takeda Pharmaceutical Company Limited (Takeda) opened its then in-house research center to outside organizations. It is currently operated by iPark Institute, a spin-off venture from Takeda. Shonan iPark aims to become a place where industry, government, and academia from a wide range of industries and sizes can come together to accelerate health innovation. Shonan iPark is currently home to about 190 companies and more than 2,400 people (as of May, 2025) including Big Pharma like Takeda, Chugai, Mitsubishi-Tanabe, and also Japanese and Korean startups.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}